Ken Charteris Group Chief Executive Officer Ken is a veteran of multiple biotech and pharmaceutical companies over the past three decades as CEO, Managing Director and Chairman. In previous Executive roles Ken has had full P&L and balance sheet responsibility including legal and financial compliance in listed and international structures, leading businesses with revenue exceeding $200m and asset bases within $100m - $500m. Ken has a proven track record in hands on roles within major listed international companies improving profit growth and effecting share price increase. Ken was involved in various senior levels within THC since prior to listing on the ASX, Ken has been instrumental in the execution of the Company’s strategic plan, including the acquisition of THC’s manufacturing facility and the securing of commercial partnerships with Endoca (Europe). Ken has a specific mandate to drive future acquisitions and alliances for THC Global.